According to Nuvectis Pharma's latest financial reports the company's current EPS (TTM) is -$1.55. In 2022 the company made an earnings per share (EPS) of -$1.50 a decrease over its 2021 EPS that were of -$1.06.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.55 | 3.33% |
2022 | -$1.50 | 42.18% |
2021 | -$1.06 |